Michael Best Partner James Lawrence was quoted in Women’s Wear Daily’s article, “CBD Brands Face FDA Scrutiny on Marketing Claims” on December 2, 2019.
The agency is targeting dubious CBD health claims, and warning about the lack of safety information about the uber hyped ingredient.
What can brands selling CBD products actually say about this elusive darling of the beauty and wellness market? Nothing too specific, if the latest warnings by federal public health regulators are any indication.
“There’s a federal component with the FDA and FTC and a state component, and brands have to think through both,” said James Lawrence, partner at Michael Best & Friedrich LLP, who advises clients on FDA issues.
To read the full article, click here.